ArticleClinical Medicine Insights. Oncology2025
Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study.
Qinglin Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.